USE OF HSP90 INHIBITORS TO OVERCOME TRASTUZUMAB RESISITANCE IN THE MINOR VARIANT OF HER2 P95HER2 IN BREAST CANCER
| dc.contributor.advisor | Beyer, Rachel | |
| dc.contributor.author | Alraddadi, Mohammed | |
| dc.contributor.department | Department of Biology | en_US |
| dc.contributor.program | Biomedical Science | en_US |
| dc.date.accessioned | 2018-12-14T17:00:12Z | |
| dc.date.available | 2018-12-14T17:00:12Z | |
| dc.date.issued | 2018-11-30 | |
| dc.genre | Mock Grant Proposals | en_US |
| dc.identifier | doi:10.13016/M2P26Q752 | |
| dc.identifier.uri | http://hdl.handle.net/11603/12264 | |
| dc.language.iso | en_US | en_US |
| dc.relation.isAvailableAt | Hood College | |
| dc.title | USE OF HSP90 INHIBITORS TO OVERCOME TRASTUZUMAB RESISITANCE IN THE MINOR VARIANT OF HER2 P95HER2 IN BREAST CANCER | en_US |
| dc.type | Text | en_US |